Geetha P. Bansal

Array ( [id] => 1445926 [patent_doc_number] => 06368598 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Drug complex for treatment of metastatic prostate cancer' [patent_app_type] => B1 [patent_app_number] => 09/110822 [patent_app_country] => US [patent_app_date] => 1998-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 5456 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368598.pdf [firstpage_image] =>[orig_patent_app_number] => 09110822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4280978 [patent_doc_number] => 06210700 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Enhancement of transplant graft survival through nutritional immunomodulation with omega-9 fatty acid dietary supplement therapy' [patent_app_type] => 1 [patent_app_number] => 9/108337 [patent_app_country] => US [patent_app_date] => 1998-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3966 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/210/06210700.pdf [firstpage_image] =>[orig_patent_app_number] => 108337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151063 [patent_doc_number] => 06156302 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes' [patent_app_type] => 1 [patent_app_number] => 9/107696 [patent_app_country] => US [patent_app_date] => 1998-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 8 [patent_no_of_words] => 13044 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156302.pdf [firstpage_image] =>[orig_patent_app_number] => 107696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640639 [patent_doc_number] => 06395272 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Therapeutic compounds comprised of anti-Fc receptor antibodies' [patent_app_type] => B1 [patent_app_number] => 09/102716 [patent_app_country] => US [patent_app_date] => 1998-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 49 [patent_no_of_words] => 23009 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395272.pdf [firstpage_image] =>[orig_patent_app_number] => 09102716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493347 [patent_doc_number] => 06403087 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Soluble lymphotoxin- receptors as therapeutic agents for the treatment of immunological disease' [patent_app_type] => B1 [patent_app_number] => 09/000166 [patent_app_country] => US [patent_app_date] => 1998-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 17256 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403087.pdf [firstpage_image] =>[orig_patent_app_number] => 09000166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4324285 [patent_doc_number] => 06312691 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Lymphotoxin-.alpha./.beta. complexes and anti-lympotoxin-.beta. receptor antibodies as anti-tumor agents' [patent_app_type] => 1 [patent_app_number] => 8/875560 [patent_app_country] => US [patent_app_date] => 1998-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20104 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312691.pdf [firstpage_image] =>[orig_patent_app_number] => 875560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4327421 [patent_doc_number] => 06312895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Human selenium-binding protein' [patent_app_type] => 1 [patent_app_number] => 9/088641 [patent_app_country] => US [patent_app_date] => 1998-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20323 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312895.pdf [firstpage_image] =>[orig_patent_app_number] => 088641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4400942 [patent_doc_number] => 06231853 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Human glutathione peroxidase-6' [patent_app_type] => 1 [patent_app_number] => 9/088549 [patent_app_country] => US [patent_app_date] => 1998-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21092 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/231/06231853.pdf [firstpage_image] =>[orig_patent_app_number] => 088549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4361650 [patent_doc_number] => 06191269 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Selective induction of cell death by delivery of amino-terminal interleukin-1-.alpha. pro-piece polypeptide' [patent_app_type] => 1 [patent_app_number] => 9/085305 [patent_app_country] => US [patent_app_date] => 1998-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 20896 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/191/06191269.pdf [firstpage_image] =>[orig_patent_app_number] => 085305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406740 [patent_doc_number] => 06265150 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Phage antibodies' [patent_app_type] => 1 [patent_app_number] => 9/085072 [patent_app_country] => US [patent_app_date] => 1998-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3791 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265150.pdf [firstpage_image] =>[orig_patent_app_number] => 085072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4249091 [patent_doc_number] => 06207458 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Proteins capable of regulating NF-.kappa.B JNK and apoptosis pathways and methods of using the same' [patent_app_type] => 1 [patent_app_number] => 9/074044 [patent_app_country] => US [patent_app_date] => 1998-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 44 [patent_no_of_words] => 18745 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207458.pdf [firstpage_image] =>[orig_patent_app_number] => 074044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4372582 [patent_doc_number] => 06303126 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Treatment of fibrosis by HGF' [patent_app_type] => 1 [patent_app_number] => 9/072742 [patent_app_country] => US [patent_app_date] => 1998-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 16 [patent_no_of_words] => 4679 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303126.pdf [firstpage_image] =>[orig_patent_app_number] => 072742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288029 [patent_doc_number] => 06197278 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Method of imaging cell death in vivo' [patent_app_type] => 1 [patent_app_number] => 9/069878 [patent_app_country] => US [patent_app_date] => 1998-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 9475 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197278.pdf [firstpage_image] =>[orig_patent_app_number] => 069878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4148443 [patent_doc_number] => 06123941 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Method for restoration of normal phenotype in cancer cells' [patent_app_type] => 1 [patent_app_number] => 9/067964 [patent_app_country] => US [patent_app_date] => 1998-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 8714 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/123/06123941.pdf [firstpage_image] =>[orig_patent_app_number] => 067964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4167961 [patent_doc_number] => 06140113 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Polynucleotides encoding molecular complexes which modify immune responses' [patent_app_type] => 1 [patent_app_number] => 9/063276 [patent_app_country] => US [patent_app_date] => 1998-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 45 [patent_no_of_words] => 18514 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140113.pdf [firstpage_image] =>[orig_patent_app_number] => 063276 [rel_patent_id] =>[rel_patent_doc_number] =>)